A detailed history of Granahan Investment Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Granahan Investment Management, LLC holds 312,520 shares of PRTA stock, worth $4.76 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
312,520
Previous 335,660 6.89%
Holding current value
$4.76 Million
Previous $6.93 Million 24.54%
% of portfolio
0.22%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.73 - $24.79 $387,132 - $573,640
-23,140 Reduced 6.89%
312,520 $5.23 Million
Q2 2024

Aug 14, 2024

BUY
$19.54 - $26.15 $33,999 - $45,501
1,740 Added 0.52%
335,660 $6.93 Million
Q1 2024

May 15, 2024

SELL
$24.75 - $40.66 $2.06 Million - $3.38 Million
-83,237 Reduced 19.95%
333,920 $8.27 Million
Q4 2023

Feb 14, 2024

BUY
$32.31 - $52.32 $2.23 Million - $3.61 Million
69,092 Added 19.85%
417,157 $15.2 Million
Q3 2023

Nov 14, 2023

BUY
$47.3 - $70.6 $2.51 Million - $3.74 Million
53,008 Added 17.97%
348,065 $16.8 Million
Q2 2023

Aug 14, 2023

BUY
$48.26 - $78.59 $3.01 Million - $4.91 Million
62,429 Added 26.84%
295,057 $20.1 Million
Q1 2023

May 15, 2023

BUY
$46.97 - $58.27 $1.54 Million - $1.91 Million
32,702 Added 16.36%
232,628 $11.3 Million
Q4 2022

Feb 14, 2023

BUY
$52.05 - $65.0 $3.06 Million - $3.82 Million
58,818 Added 41.68%
199,926 $12 Million
Q3 2022

Nov 14, 2022

SELL
$25.16 - $60.63 $458,339 - $1.1 Million
-18,217 Reduced 11.43%
141,108 $8.56 Million
Q2 2022

Aug 15, 2022

BUY
$22.73 - $39.98 $800,527 - $1.41 Million
35,219 Added 28.38%
159,325 $4.33 Million
Q1 2022

May 16, 2022

BUY
$30.27 - $49.22 $1.03 Million - $1.67 Million
33,927 Added 37.62%
124,106 $4.54 Million
Q4 2021

Feb 14, 2022

BUY
$42.11 - $73.26 $1.89 Million - $3.29 Million
44,875 Added 99.05%
90,179 $4.46 Million
Q3 2021

Nov 15, 2021

BUY
$48.2 - $78.89 $2.18 Million - $3.57 Million
45,304 New
45,304 $3.23 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.